| Longitudinal Evaluation of Gastric Emptying and Accommodation in Children With Dyspepsia (NCT05055336) | University of Miami | 2022-05-01 |
| Intestinal Permeability and Gastroparesis (NCT04894656) | Mayo Clinic | 2022-04-01 |
| Safety, PK and Efficacy of PCS12852 on Gastric Emptying Rate in Patients With Moderate to Severe Gastroparesis (NCT05270460) | Processa Pharmaceuticals | 2022-03-09 |
| Endoscopic Myotomy of the Pylorus To Improve Emptying and Symptoms Trial (NCT05039424) | Matthew Allemang | 2022-02-23 |
| Gastroparesis in Cystic Fibrosis (NCT05223881) | University of Miami | 2022-02-14 |
| Magnetically Controlled Capsule Endoscopy Feasibility Study in Gastric Motility (NCT05004012) | University of California, Los Angeles | 2021-12-01 |
| Prospective Evaluation of the Clinical Utility of Peroral Endoscopic Myotomy for Gastrointestinal Motility Disorders (NCT05905016) | AdventHealth | 2021-10-01 |
| A Study to Evaluate the Safety and Tolerability of Virtual Reality to Treat Gastroparesis (NCT05079568) | Mayo Clinic | 2021-10-01 |
| BSGM to Evaluate Patients With GI Symptoms (NCT05880199) | Children's Hospital of Philadelphia | 2021-10-01 |
| Use of EndoFLIP and Manometry Prior to G-POEM (NCT04844190) | Northwestern University | 2021-09-15 |
| Atmo SmartPill Comparison in Gastroparetic and Slow Transit Constipation Patients (NCT04977063) | Atmo Biosciences Pty Ltd | 2021-08-15 |
| ConMed Beamer Study (NCT04752670) | Baylor College of Medicine | 2021-05-27 |
| ABVN Phase 2-Studying the Effect of Stimulation on the Auricular Branch of the Vagal Nerve -B (NCT06827548) | Indiana University | 2021-05-13 |
| Non-invasive Vagal Nerve Stimulation (nVNS) for Symptomatic Exacerbation of Nausea in Patients With Gastroparesis and Related Disorders (NCT04857281) | Johns Hopkins University | 2021-04-19 |
| Endoscopic Surgery for Gastrointestinal Disorders: A Multicenter Registry Study (NCT05041608) | Advanced Endoscopy Research, Robert Wood Johnson Medical School Rutgers University | 2021-02-17 |
| GEBT Lot-to-Lot and Biological Variability (NCT04772261) | Cairn Diagnostics | 2021-02-05 |
| GEBT Telehealth Administration Usability Study (NCT04684992) | Cairn Diagnostics | 2020-12-11 |
| 13C-Spirulina Nitrogen Content GEBT Study (NCT04635306) | Cairn Diagnostics | 2020-10-21 |
| Indiana University Gastric Electrical Stimulation Registry (NCT05047289) | Indiana University | 2020-10-20 |
| ABCA2 GIRMS Analytical Validation Clinical Performance Study (NCT04607304) | Cairn Diagnostics | 2020-10-08 |
| Transcutaneous Electroacupuncture for Gastrointestinal Motility Disorders (NCT04349891) | Johns Hopkins University | 2020-10-01 |
| ABVN Phase 2-Studying the Effect of Stimulation on the Auricular Branch of the Vagal Nerve (NCT06491758) | Indiana University | 2020-06-02 |
| Safety and Efficacy of GPOEM in the Treatment of Gastroparesis (NCT04349670) | IRCCS San Raffaele | 2020-06-01 |
| Use of Intrapyloric Botulinum Injections in Children (NCT04250844) | Boston Children's Hospital | 2020-03-10 |
| Pioglitazone for Idiopathic Gastroparesis (NCT04300127) | Johns Hopkins University | 2019-10-24 |
| A Phase 2 Study of CIN-102 in Adults With Idiopathic and Diabetic Gastroparesis (NCT04026997) | CinDome Pharma, Inc. | 2019-09-11 |
| Efficacy and Safety of Cannabidiol for Gastroparesis and Functional Dyspepsia (NCT03941288) | Mayo Clinic | 2019-09-04 |
| Vagus Nerve Response in Gastroparesis Patients (NCT04207996) | Indiana University | 2019-09-01 |
| Buspirone for Early Satiety and Symptoms of Gastroparesis (NCT03587142) | Johns Hopkins Bloomberg School of Public Health | 2019-08-27 |
| Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis (NCT04028492) | Vanda Pharmaceuticals | 2019-08-20 |
| Study to Intervene With Nutrition for Gastroparesis (NCT03987672) | Stanford University | 2019-08-01 |
| Magnetic Resonance Imaging of the Brain and Stomach in Healthy Volunteers and Gastroparesis (NCT04282317) | Indiana University | 2019-08-01 |
| Transpyloric Stenting as a Predictor for G-POEM for Refractory Gastroparesis (NCT04287647) | Northwestern University | 2019-05-15 |
| Nutritional Drink in Gastroparesis (NCT03500354) | Johns Hopkins University | 2019-05-10 |
| A Study of CNSA-001 in Women With Diabetic Gastroparesis (NCT03712124) | PTC Therapeutics | 2019-02-27 |
| Gastroparesis Registry 3 (NCT03680859) | Johns Hopkins Bloomberg School of Public Health | 2019-01-24 |
| Pediatric Gastroparesis Registry (NCT03680820) | Johns Hopkins Bloomberg School of Public Health | 2019-01-23 |
| Open Label Transdermal Granisetron to Relieve Chronic Nausea and Emesis (NCT04501211) | Indiana University | 2019-01-01 |
| GI-Challenge Study for Gastroparesis Patients and Healthy Controls (NCT03896126) | Stanford University | 2019-01-01 |
| Diabetic Gastroparesis Study 05 (NCT03786380) | Allergan | 2018-12-20 |
| Central and Peripheral Effects of Cognitive Behavioral Therapy on Brain-Gut Axis Signaling in Gastroparetic Patients (NCT03531450) | Massachusetts General Hospital | 2018-12-07 |
| Ultrasound Assessment of Gastric Contents in Fasted Surgical Patients With Previous Subtotal Gastrectomy (NCT03802006) | Seoul National University Hospital | 2018-11-15 |
| Endoscopic Clips Versus Overstich Suturing System Device for Closure of Mucosotomy After G-POEM (NCT03679104) | Institute for Clinical and Experimental Medicine | 2018-11-01 |
| Prospective Evaluation of the Efficacy and Safety of Submucosal Endoscopy (NCT03626350) | University of Colorado, Denver | 2018-06-12 |
| Role of Gastric Ultrasound in Preoperative Assessment of Gastric Volume in Diabetic Patients. (NCT03438305) | Cairo University | 2018-03-01 |
| Study to Evaluate the Safety and Efficacy of Relamorelin in Participants With Diabetic Gastroparesis Study 02 (NCT03426345) | Allergan | 2018-02-16 |
| A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04 (NCT03383146) | Allergan | 2018-02-01 |
| A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03 (NCT03420781) | Allergan | 2018-01-24 |
| The Effect of Gluten-free Diet in Type 1 Diabetics With Dyspepsia Symptoms (NCT03089632) | McMaster University | 2017-12-15 |
| Endoscopic Pyloromyotomy for Refractory Gastroparesis (NCT03356067) | Institute for Clinical and Experimental Medicine | 2017-12-01 |
| Ultrasound Assessment of Gastric Contents in Fasted Patient Undergoing Cholecystectomy (NCT03259841) | SMG-SNU Boramae Medical Center | 2017-10-31 |
| GPOEM Versus SHAM as a Treatement of Gastroparesis (NCT04552184) | Erasme University Hospital | 2017-10-10 |
| Protease Activated Receptor-2 and Gastrointestinal Dysfunction in Critical Illness (NCT03011151) | Boston Children's Hospital | 2017-08-01 |
| Vagal Nerve Stimulation for Gastroparesis (NCT03120325) | Stanford University | 2017-03-01 |
| Transcutaneous Electroacupuncture for Gastric Complications of Scleroderma (NCT03294616) | Johns Hopkins University | 2017-02-06 |
| Gastric Electrical Stimulation (GES) and Pyloroplasty for the Treatment of Gastroparesis (NCT03123809) | Texas Tech University Health Sciences Center, El Paso | 2017-01-10 |
| Per-oral Endoscopy Pyloromyotomy (G-POEM) in the Treatment of Refractory Diabetic Gastroparesis : Prospective Evaluation of Efficacy (NCT02927886) | Assistance Publique Hopitaux De Marseille | 2016-11-01 |
| Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis (NCT02970968) | Vanda Pharmaceuticals | 2016-11-01 |
| Feasibility of Endoscopic Pylorotomy in the Treatment of Refractory Gastroparesis, Pilot Study. (NCT02779920) | University Hospital, Limoges | 2016-04-01 |
| Effect of Vibrant Capsule on Gastric Emptying and Antropyloroduodenal Motility in Healthy Volunteers (NCT02736799) | Vibrant Ltd. | 2016-03-01 |
| Determination of the Characteristics of Isometric Gastric Motility Measurement in Healthy Volunteers (NCT03441230) | Prof Dr Jan Tack | 2016-02-15 |
| Acupuncture for Diabetic Gastroparalysis: a Randomized Controlled Trial (NCT02594397) | The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine | 2015-12-01 |
| Medtronic Enterra II Neurostimulator (NCT06215547) | Methodist Health System | 2015-09-15 |
| Effects of Sitagliptin on Gastric Emptying, Glycaemia and Blood Pressure in Type 2 Diabetes (NCT02324010) | Royal Adelaide Hospital | 2015-07-01 |
| Pyloric Sphincter Pressure and Geometry Assessment Using EndoFlip (NCT02446119) | Temple University | 2015-05-01 |
| The Diabetic and Idiopathic Gastroparesis Efficacy, Safety, and Tolerability (DIGEST) Study (NCT02267525) | Theravance Biopharma | 2014-12-01 |
| Indiana University Gastrointestinal Motility Diagnosis Registry (NCT04506593) | Indiana University | 2014-11-01 |
| Effect of Celiac Plexus Block on Gastric Emptying and Symptoms Caused by Gastroparesis (NCT02420925) | Linda Nguyen | 2014-10-01 |
| A Study to Evaluate the Effect of Camicinal on Gastroparesis Symptoms in Type 1 and 2 Diabetic Subjects With Gastroparesis (NCT02210000) | GlaxoSmithKline | 2014-08-27 |
| Modulation of Heme Oxygenase 1 by Nizatidine and Lisinopril in Healthy Subjects (NCT02232308) | Adil Bharucha | 2014-07-01 |
| Study Evaluating the Effect of TC-6499 on Gastric Emptying Time in Diabetic Subjects With Gastroparesis (NCT02187094) | Targacept Inc. | 2014-06-01 |
| Autonomic and Enteric Profiling (NCT03178370) | University of Louisville | 2014-03-06 |
| Prucalopride Versus Placebo in Gastroparesis (NCT02031081) | University of Calgary | 2014-03-01 |
| Clinical Management With SPM System and Validation of the SPM 5 Hour Cutoff in Patients With Symptoms of Gastroparesis (NCT02022826) | Medtronic - MITG | 2014-01-01 |
| GI Neuromuscular Pathology Prospective Registry (NCT02165059) | Indiana University | 2013-12-01 |
| Drug Trial of Lixisenatide on Gastric Emptying and Blood Pressure Drops in Type 2 Diabetics and Healthy People (NCT02308254) | Royal Adelaide Hospital | 2013-11-01 |
| Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin Trial (NCT01149369) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2013-04-01 |
| Compassionate Use of Domperidone for Refractory Gastroparesis (NCT04699591) | Jose Cocjin | 2013-04-01 |
| Escalating Temporary Gastric Electrical Stimulation (GES) for Severe Gastroparesis (NCT02164591) | Indiana University | 2013-02-01 |
| IS There a Correlation Between Sypmtoms of Gastroparesis and the Duration of Video Caspule Retention in the Stomach (NCT01858220) | Sheba Medical Center | 2013-01-01 |
| Gastroparesis Outcome Longitudinal Database Enrolled Numerically (NCT03876288) | University of Louisville | 2013-01-01 |
| Phase 2 Study of Velusetrag in Diabetic or Idiopathic Gastroparesis (NCT01718938) | Theravance Biopharma | 2012-12-01 |
| Sancuso® for Gastroparesis: An Open Label Study. (NCT01989221) | Temple University | 2012-11-01 |
| Cardiac Vagal Effects of GES in Patients With Gastroparesis and Vagal Nerve Action Potentials in Vagus Nerve (NCT02159586) | Indiana University | 2012-11-01 |
| Domperidone in Treating Patients With Gastrointestinal Disorders (NCT01696734) | M.D. Anderson Cancer Center | 2012-10-23 |
| Endoscopic Full Thickness Biopsy, Gastric Wall. (NCT01650714) | Mayo Clinic | 2012-09-01 |
| Gastroparesis Registry 2 (NCT01696747) | Johns Hopkins Bloomberg School of Public Health | 2012-07-01 |
| A Study to Assess the Effect of Repeat Doses of GSK962040 on the Pharmacokinetics of L-DOPA in Subjects With Parkinson's Disease Exhibiting Delayed Gastric Emptying (NCT01602549) | GlaxoSmithKline | 2012-07-01 |
| Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis (NCT01571297) | Motus Therapeutics, Inc. | 2012-04-01 |
| Antro-pyloro-duodenal Motility in Idiopathic Gastroparesis (NCT01519180) | University Hospital, Rouen | 2012-01-01 |
| Prucalopride Versus Placebo in Gastroparesis (NCT02510976) | Universitaire Ziekenhuizen KU Leuven | 2011-11-01 |
| Acupuncture Treatment for Gastroparesis: a Pilot Study (NCT01643577) | Johns Hopkins University | 2011-11-01 |
| Affects of Once-daily Oral Administration of TZP-102 on the Treatment of Symptoms Associated With Diabetic Gastroparesis (NCT01452815) | Tranzyme, Inc. | 2011-09-01 |
| Study to Assess Pharmacodynamics of RM-131 in Patients With Diabetic Gastroparesis (NCT01394055) | Motus Therapeutics, Inc. | 2011-07-01 |
| Dose Response of 28 Days of Dosing of GSK962040 in Type I and II Diabetic Male and Female Subjects With Gastroparesis (NCT01262898) | GlaxoSmithKline | 2011-05-03 |
| Daily Tadalafil and Gastric Emptying Time in Diabetic Gastroparesis (NCT01326117) | Mark Feinglos | 2011-04-01 |
| Patient Understanding (Cognitive Debriefing) of a Daily Diary of Gastroparesis Symptoms (NCT01316484) | Tranzyme, Inc. | 2011-03-01 |
| A Study to Evaluate the Pharmacokinetics and Absolute Bioavailability of GSK962040 Given as an Oral Dose Simultaneously With an Intravenous Microtracer Dose of [14C]-GSK962040 in Healthy Volunteers (NCT01267071) | GlaxoSmithKline | 2010-06-14 |
| Idiopathic Gastroparesis Registry Using a Predominant-Symptom Classification (NCT01173484) | University of Louisville | 2010-06-01 |
| Impact of KUVAN® on Gastric Relaxation in Women With Diabetic Gastroparesis. (NCT01135186) | Stanford University | 2010-05-01 |